Hiroji Uemura

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Renal Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of clinical oncology

Molecular cancer therapeutics

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A phase 1 study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Conor Chandler, Heather Burnett, Kassandra Schaible, Vishnu Senthil, Masafumi Kato, Yuji Miura, Takahiro Osawa, Hiroji Uemura, Hiroyo Kuwabara
Cost-effectiveness analysis of cabozantinib compared with everolimus, axitinib, and nivolumab in subsequent line advanced renal cell carcinoma in Japan. Journal of medical economics (2023)
Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, Ryuji Matsumoto, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane
TAS0313 Plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma. Molecular cancer therapeutics (2023)
Hiroji Uemura, Kazuki Kobayashi, Akira Yokomizo, Shiro Hinotsu, Shigeo Horie, Yoshiyuki Kakehi, Norio Nonomura, Osamu Ogawa, Mototsugu Oya, Kazuhiro Suzuki, Atsushi Saito, Keiko Asakawa, Satoshi Uno, Seiji Naito
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study. International journal of clinical oncology 27 (10) (2022)
Hiroji Uemura, Hisashi Matsushima, Kazuki Kobayashi, Hiroya Mizusawa, Hiroaki Nishimatsu, Karim Fizazi, Matthew Smith, Neal Shore, Teuvo Tammela, Ken-Ichi Tabata, Nobuaki Matsubara, Masahiro Iinuma, Hirotsugu Uemura, Mototsugu Oya, Tetsuo Momma, Mutsushi Kawakita, Satoshi Fukasawa, Tadahiro Kobayashi, Iris Kuss, Marie-Aude Le Berre, Amir Snapir, Toni Sarapohja, Kazuhiro Suzuki
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial. International journal of clinical oncology 26 (3) (2020)
Tomohiro Tsuchiya, Keiichiro Imanaka, Yuki Iwaki, Ryo Oyama, Katsuyoshi Hashine, Akito Yamaguchi, Hiroji Uemura
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer. International journal of clinical oncology 24 (12) (2019)